| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/06/2002 | WO2001090129A3 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds |
| 06/06/2002 | WO2001090068A3 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases |
| 06/06/2002 | WO2001088116A9 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
| 06/06/2002 | WO2001079442A3 Albumin fusion proteins |
| 06/06/2002 | WO2001072287B1 Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression |
| 06/06/2002 | WO2001068071A3 Use of natural chrysanthone compounds having antiangiogenic activity |
| 06/06/2002 | WO2001064907A3 Lipid metabolism enzymes |
| 06/06/2002 | WO2001052856A3 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 06/06/2002 | WO2001036645A3 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 06/06/2002 | WO2001021148B1 No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product |
| 06/06/2002 | US20020068830 Such as 1-((1-(3-(cyclopentyloxy)-4-methoxyphenyl) cyclopropyl)methyl)-1,3-dihydro-2H-imidazol-2-one for allergies, atopic and inflammatory diseases wherein activity of phosphodiesterase is altered |
| 06/06/2002 | US20020068766 Composition and method of use |
| 06/06/2002 | US20020068756 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 06/06/2002 | US20020068746 Pyrrolo[2,3-d]pyrimidine compounds |
| 06/06/2002 | US20020068729 Quaternary salts of substituted imidazoles, oxazoles and thiazoles |
| 06/06/2002 | US20020068723 Altering the conformational equilibrium of the A- ring to favor a chair conformation that presents the 1 alpha-hydroxyl in the axial orientation. |
| 06/06/2002 | US20020068706 Inhibitors of cyclin-dependent kinases (CDKs), particularly CDK/cyclin complexes, can be used to control proliferation and/or differentiation of cells |
| 06/06/2002 | US20020068697 Peptides blocking vascular endothelial growth factor (VEGF) -mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 06/06/2002 | US20020068341 Human kallikrein |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068089 Comprises biocompatible hydrophilic cationic microparticles and cell adhesion promoter implanted into the lower esophageal sphincter |
| 06/06/2002 | US20020068072 Treating lichens, prurigo, pruriginous toxicoderma and severe pruritus of neurogenic origin |
| 06/06/2002 | US20020068065 Pharmaceutical composition having specific water activity |
| 06/06/2002 | US20020068045 Such as neural progenitor cells capable of giving rise to mature somatic cells including neural cells and/or glial cells recognizable by expression of specific markers |
| 06/06/2002 | CA2457925A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | CA2430401A1 Uses of mammalian genes and related reagents |
| 06/06/2002 | CA2430354A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | CA2430346A1 Beautifying foods and drinks and peroral beautifying preparations |
| 06/06/2002 | CA2430311A1 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | CA2430298A1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/06/2002 | CA2430296A1 Anti-proliferative drugs |
| 06/06/2002 | CA2430291A1 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma |
| 06/06/2002 | CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | CA2430133A1 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 06/06/2002 | CA2430010A1 Treatments for neurogenetic disorders, impulse control disorders, and wound healing |
| 06/06/2002 | CA2429469A1 Human elongase genes and uses thereof |
| 06/06/2002 | CA2429382A1 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | CA2364350A1 Personal care formulations |
| 06/05/2002 | EP1210946A1 Astringent composition and method of use |
| 06/05/2002 | EP1210937A2 Device for topical treatment of acne and its method of manufacture |
| 06/05/2002 | EP1210605A2 Analysis and treatment of body weight and eating disorders |
| 06/05/2002 | EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6 |
| 06/05/2002 | EP1210426A2 Polymorphisms in a klotho gene |
| 06/05/2002 | EP1210419A2 Human transmembrane proteins |
| 06/05/2002 | EP1210350A1 Water soluble sdz-rad esters |
| 06/05/2002 | EP1210348A1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 06/05/2002 | EP1210346A2 New active marine alkaloids |
| 06/05/2002 | EP1210341A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 06/05/2002 | EP1210335A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 06/05/2002 | EP1210327A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 06/05/2002 | EP1210326A2 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 06/05/2002 | EP1210325A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP1210320A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP1210132A1 Herb medicine composition to be contained in sanitary materials for infants |
| 06/05/2002 | EP1210130A1 Solid wound healing formulations containing fibronectin |
| 06/05/2002 | EP1210121A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 06/05/2002 | EP1210108A2 Use of leptin in inhibition of endothelial cell proliferation |
| 06/05/2002 | EP1210100A1 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 06/05/2002 | EP1210094A1 Herbal compositions and uses for the treatment of allergic reactions |
| 06/05/2002 | EP1210086A1 Promotion of wound healing |
| 06/05/2002 | EP1210079A2 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 06/05/2002 | EP1210078A1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 06/05/2002 | EP1210077A1 Compositions and systems for the treatment of hyperpigmentation |
| 06/05/2002 | EP1210075A1 Compositions and methods for modification of skin lipid content |
| 06/05/2002 | EP1210073A1 Sunscreen agent for oral administration |
| 06/05/2002 | EP1210065A1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 06/05/2002 | EP1210063A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 06/05/2002 | EP1210046A1 Enhanced wound coverage to enhance wound healing |
| 06/05/2002 | EP1137438B1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 06/05/2002 | EP1109573B1 PHARMACEUTICAL COMPOSITIONS COMPRISING FACTOR XIIIa FOR NERVE HEALING |
| 06/05/2002 | EP0966430B1 Anti-inflammatory compounds |
| 06/05/2002 | EP0930888B1 Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea) |
| 06/05/2002 | EP0884997B1 Compositions containing an antifungal and a sulfur compound |
| 06/05/2002 | EP0788361B1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 06/05/2002 | EP0711282B1 Compounds as pde iv and tnf inhibitors |
| 06/05/2002 | EP0642516B1 Macrocyclic immunomodulators |
| 06/05/2002 | EP0632723B1 Use of transglutaminase inhibitor for the treatment of scar tissue |
| 06/05/2002 | EP0612211B1 Alteration of rate and character of hair growth |
| 06/05/2002 | CN1352650A Recombinant IL-18 antagonist useful in treatment of IL-18 mediated disorders |
| 06/05/2002 | CN1352644A I-amino triazolo [4,3-alpha] quinazoline -5-ones and/or -5-thiones inhibiting phosphodiesterase IV |
| 06/05/2002 | CN1352636A Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 06/05/2002 | CN1352554A IL-8 receptor antagaonists |
| 06/05/2002 | CN1351887A Externally applied Chinese medicine decoction |
| 06/05/2002 | CN1351879A Spot removing and face nursing capsule |
| 06/05/2002 | CN1351876A Chinese medicine external use lotion for treating skin diseases and its preparing method |
| 06/05/2002 | CN1351874A Medicine for curing human body burns and scalds |
| 06/05/2002 | CN1351872A Chinese herbal medicine for curing comedo and acne |
| 06/05/2002 | CN1085947C Powder prepared with colophony, realgar and Huangdan |
| 06/05/2002 | CN1085946C External medicine with anti-infections and recovery function |
| 06/04/2002 | US6399797 Vitamin D analogues |
| 06/04/2002 | US6399780 Kinase inhibitors; anticancer agents |
| 06/04/2002 | US6399656 Using a benzopyran-3-carboxamide compound |
| 06/04/2002 | US6399651 Method of treating dermatoses using avermectin compound |
| 06/04/2002 | US6399648 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 06/04/2002 | US6399636 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease (copd), eosinophilic granuloma, psoriasis and septic shock, ulcerative colitis, crohn's disease, reperfusion injury of the myocardium and brain |
| 06/04/2002 | US6399626 Useful in inducing immunosuppression and in treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, vascular disease |
| 06/04/2002 | US6399603 Therapeutic heterocycles |
| 06/04/2002 | US6399598 Diheterocyclic metalloprotease inhibitors |
| 06/04/2002 | US6399590 Phosphoglycolipid and methods for its use |
| 06/04/2002 | US6399370 Compositions and methods for use of defensin |